Skip to main content
. 2019 Jan 9;30(1):10–20. doi: 10.1089/hum.2018.103

Table 5.

LV protein levels (immunoblotting)

        p
Protein Con (4) HF (4) HF + UCn3 (4) Control vs. HF HF vs. HF + UCn3
p-PKA-RIIa 0.6 ± 0.1 0.7 ± 0.1 0.6 ± 0.1 1 0.6
p-PKA-RIIb 0.3 ± 0.15 0.3 ± 0.03 0.2 ± 0.03 1 0.8
Total-PKA 0.4 ± 0.01 0.3 ± 0.02 0.3 ± 0.02 1 0.8
p-PKA/Total 1.8 ± 0.3 2.0 ± 0.10 1.9 ± 0.1 1 0.8
CamKII 0.6 ± 0.1 0.5 ± 0.1 0.6 ± 0.1 1 0.8
p-CamKII 0.5 ± 0.1 0.4 ± 0.02 0.6 ± 0.1 0.8 0.2
p-CamKII/Total 0.9 ± 0.15 0.9 ± 0.1 1.1 ± 0.2 1 1
p-RYR2/Total 2.2 ± 0.4 0.7 ± 0.1 1.2 ± 0.1 0.01 0.06
p16-PLB 0.1 ± 0.1 0.7 ± 0.1 0.9 ± 0.11 1 0.8
p16-PLB/Total 3.7 ± 0.6 1.1 ± 0.2 2.1 ± 0.5 0.01 0.2
p17-PLB 6.3 ± 0.7 2.4 ± 0.8 2.2 ± 0.4 0.02 1
p17-PLB/Total 28.6 ± 3.5 3.5 ± 1.1 5.4 ± 1.5 0.001 0.6
CARP 10.3 ± 1 14 ± 1.8 14 ± 1.1 0.2 1
MYLK3 0.6 ± 0.1 1.0 ± 0.3 0.7 ± 0.1 0.4 0.8

Immunoblotting data presenting protein levels normalized for GAPDH or vinculin. Data are mean ± SE. p-Values from a Student's t-test (unpaired, two-tailed) with Bonferroni correction for multiple comparisons; numbers in parentheses indicate group size.

p-TnI, S23/24 phosphorylated troponin I; PKA-RIIa, protein kinase A IIa; CamKII, Ca2+/calmodulin-dependent protein kinase II; RYR, ryanodine receptor; PLB, phospholamban; MYLK3, myosin light chain kinase 3.